Press Release: Poseida Therapeutics, Inc. Announces Agreement to Be Acquired by Roche Holdings, Inc.

Dow Jones01:10 ET

H.C. Wainwright Downgrades Poseida Therapeutics(PSTX.US) to Hold Rating, Cuts Target Price to $9

Moomoo News12minutes ago · Ratings

Shareholder Alert: Ademi LLP Investigates Whether Poseida Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders

Businesswire22minutes ago

Sector Update: Health Care Stocks Mixed Premarket Tuesday

MT Newswires29minutes ago

Poseida Therapeutics Analyst Ratings

Benzinga40minutes ago · Ratings

Express News | Poseida Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

Reuters43minutes ago